Literature DB >> 407604

Sensitization to cocaine stimulation in mice.

L Shuster, G Yu, A Bates.   

Abstract

Repeated administration of cocaine to B6AF1/J mice increased their running response to 20 mg/kg cocaine as much as four-fold over the response to the first injection. After four daily injections, the extent of the increase was proportional to the dose of cocaine that was used for pretreatment. Sensitization persisted for as long as 2 months after the last injection of cocaine. Cocaine-pretreated mice did not show an increased running response to either morphine or d-amphetamine. The response to cocaine was increased two-fold by treatment with morphine and three-fold by pretreatment with d-amphetamine. Pretreatment with either imipramine or reserpine did not produce sensitization to cocaine. There was no correlation between cocaine sensitization and whole-brain catecholamine levels. There were marked differences in both the running response to cocaine and the extent of cocaine sensitization betwee the parental strains, C57B1/6J and A/J. Experiments with recombinant-inbred lines, derived from C57B1/6By and BALB/cBy mice, suggest that the initial response to cocaine and the development of sensitization are controlled by different genetic determinants.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 407604     DOI: 10.1007/bf00439108

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

Review 1.  Supersensitivity-like phenomena in the central nervous system.

Authors:  S K Sharpless
Journal:  Fed Proc       Date:  1975-09

2.  A genetic analysis of the response to morphine in mice: analgesia and running.

Authors:  L Shuster; G W Webster; G Yu; B E Eleftheriou
Journal:  Psychopharmacologia       Date:  1975-06-19

3.  Effect of drugs on the uptake and metabolism of H3-norepinephrine.

Authors:  G HERTING; J AXELROD; L G WHITBY
Journal:  J Pharmacol Exp Ther       Date:  1961-11       Impact factor: 4.030

4.  ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF THE EFFECTS OF D-AMPHETAMINE UPON THE LOCOMOTOR ACTIVITY OF MICE.

Authors:  C B SMITH
Journal:  J Pharmacol Exp Ther       Date:  1963-12       Impact factor: 4.030

5.  Increasing effects of repetitive cocaine administration in the rat.

Authors:  R M Post; H Rose
Journal:  Nature       Date:  1976-04-22       Impact factor: 49.962

6.  A rapid and sensitive procedure for the combined assay of noradrenaline, dopamine AND SEROTONIN IN A SINGLE BRAIN SAMPLE.

Authors:  G B Ansell; M F Beeson
Journal:  Anal Biochem       Date:  1968-05       Impact factor: 3.365

7.  Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes.

Authors:  D W Bailey
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

8.  Letter: Cocaine, kindling, and reverse tolerance.

Authors:  R M Post; R T Kopanda
Journal:  Lancet       Date:  1975-02-15       Impact factor: 79.321

9.  Norcocaine: a pharmacologically active metabolite of cocaine found in brain.

Authors:  R L Hawks; I J Kopin; R W Colburn; N B Thoa
Journal:  Life Sci       Date:  1974-12-15       Impact factor: 5.037

10.  Increased running response to morphine in morphine-pretreated mice.

Authors:  L Shuster; G W Webster; G Yu
Journal:  J Pharmacol Exp Ther       Date:  1975-01       Impact factor: 4.030

View more
  50 in total

1.  Repeated maternal separation: differences in cocaine-induced behavioral sensitization in adult male and female mice.

Authors:  Takefumi Kikusui; Sara Faccidomo; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2004-08-21       Impact factor: 4.530

2.  Does context influence the duration of locomotor sensitization to ethanol in female DBA/2J mice?

Authors:  Stephen L Boehm; Karen J Goldfarb; Kristen M Serio; Eileen M Moore; David N Linsenbardt
Journal:  Psychopharmacology (Berl)       Date:  2007-11-30       Impact factor: 4.530

3.  Differential involvement of enkephalins in analgesic tolerance, locomotor sensitization, and conditioned place preference induced by morphine.

Authors:  Paul Marquez; Ramkumarie Baliram; Nagaraju Gajawada; Theodore C Friedman; Kabirullah Lutfy
Journal:  Behav Neurosci       Date:  2006-02       Impact factor: 1.912

4.  Individual differences in the attribution of incentive salience to a reward-related cue: influence on cocaine sensitization.

Authors:  Shelly B Flagel; Stanley J Watson; Huda Akil; Terry E Robinson
Journal:  Behav Brain Res       Date:  2007-07-21       Impact factor: 3.332

5.  Cross-sensitization of the reinforcing effects of cocaine and amphetamine in rats.

Authors:  Yu Liu; Drake Morgan; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-08-22       Impact factor: 4.530

6.  Simultaneous expression of cocaine-induced behavioral sensitization and conditioned place preference in individual rats.

Authors:  Claire M Seymour; John J Wagner
Journal:  Brain Res       Date:  2008-04-08       Impact factor: 3.252

7.  Stress and Rodent Models of Drug Addiction: Role of VTA-Accumbens-PFC-Amygdala Circuit.

Authors:  Jasmine J Yap; Klaus A Miczek
Journal:  Drug Discov Today Dis Models       Date:  2008

8.  A verification of previously identified QTLs for cocaine-induced activation using a panel of B6.A chromosome substitution strains (CSS) and A/J x C57Bl/6J F2 mice.

Authors:  Alan E Boyle; Kathryn J Gill
Journal:  Psychopharmacology (Berl)       Date:  2009-09-23       Impact factor: 4.530

Review 9.  Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.

Authors:  Samantha N Hellberg; Trinity I Russell; Mike J F Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

10.  Behavioral effects of amphetamine in streptozotocin-treated rats.

Authors:  Rajkumar J Sevak; Wouter Koek; Lynette C Daws; William Anthony Owens; Aurelio Galli; Charles P France
Journal:  Eur J Pharmacol       Date:  2007-11-28       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.